The prognostic relevance of ANXA3 for PCa was validated by IHC in prostate tissues and the decreased level of ANXA3 was also found by western blot analysis in urine samples of prostate cancer patients (11, 12). The gene discussed is ANXA3; the disease is posterior cortical atrophy.